Will A ‘Netflix’ Model Solve Antibiotic Reimbursement Challenges And Spur R&D?

Citeline Podcasts

English - July 19, 2023 11:07 - 33 minutes - 13.3 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How Downturn In Demand For EU Medtech Regulatory Talent Is Starting To Improve

Next Episode: Meeting Milestones Through Effective Biotech Trial Strategies Episode 1

In Vivo executive editor Lucie Ellis-Taitt and Infex CEO Peter Jackson explore the current state of antimicrobial resistance in the UK, and worldwide. They discuss the potential of a new “Netflix” style subscription model in the UK for antibiotic reimbursement, as well as future challenges for biotechs in the anti-infectives space.